Weekly ReportDec 22–28, 2025
Anesthesiology, week 52 edition
We read 457 papers and selected 3.
Summary
This week’s anesthesiology literature highlighted advances in opioid receptor pharmacology, enhanced-recovery analgesia, and individualized perioperative hemodynamics. Time-resolved cryo-EM provided a paradigm-shifting view of how μ-opioid receptor ligands with different efficacies follow distinct activation trajectories, while a randomized trial showed that intrathecal morphine added to TAP block substantially improved early recovery after laparoscopic colorectal surgery. Conversely, an Anesthesiology randomized trial found that extending individualized goal-directed fluid and blood-pressure therapy after esophagectomy did not reduce 30-day morbidity, challenging assumptions about protocolized postoperative hemodynamic optimization. Additional trends included AI-enabled monitoring, sustainable anesthesia, diaphragm-sparing regional blocks, delirium prediction, and precision approaches to critical care.
Selected Articles
1. Non-equilibrium snapshots of ligand efficacy at the μ-opioid receptor.
This mechanistic Nature study used time-resolved cryo-EM to capture non-equilibrium intermediates during GTP-driven activation of the μ-opioid receptor coupled to G proteins. Comparing partial, full, and super-agonists showed how ligand efficacy can be related to distinct receptor activation trajectories, providing a structural framework for understanding opioid signaling.
Impact: It provides a state-of-the-art structural explanation for ligand-dependent opioid efficacy, a central challenge in designing analgesics that preserve analgesia while reducing respiratory depression and other adverse effects.
Clinical Implications: The findings are not immediately practice-changing, but they may guide rational development of efficacy-selective or signaling-biased opioids with improved safety profiles.
Key Findings
- Time-resolved cryo-EM captured intermediate MOR-G protein activation states after GTP loading.
- Partial, full, and super-agonists produced distinguishable activation trajectories.
- Structural intermediates linked ligand efficacy to receptor signaling dynamics.
2. Intrathecal Morphine for Enhanced Recovery After Laparoscopic Colorectal Surgery: A Randomized Clinical Trial.
In a prospective double-blind randomized trial of 252 adults undergoing laparoscopic colorectal surgery within an ERAS pathway, intrathecal morphine at 3 μg/kg added to liposomal-bupivacaine TAP block improved 24-hour QoR-15 scores by 12.21 points and reduced opioid consumption. Nausea decreased, but pruritus increased substantially.
Impact: It provides strong, patient-centered randomized evidence for a practical modification of multimodal ERAS analgesia, with a clinically meaningful improvement in early recovery quality.
Clinical Implications: Intrathecal morphine plus TAP block can be considered for laparoscopic colorectal surgery, with informed counseling and monitoring for pruritus and other neuraxial opioid effects.
Key Findings
- 24-hour QoR-15 improved by 12.21 points with intrathecal morphine plus TAP block versus placebo.
- Postoperative morphine-equivalent consumption decreased by 6.59 mg.
- Nausea decreased, while pruritus increased from 3.2% to 19.0%.
3. Individualised Perioperative Blood Pressure and Fluid Therapy in Oesophagectomy: A Prospective, Single-Blind Randomised Controlled Trial.
In a single-center randomized trial of 100 patients undergoing esophagectomy, extending goal-directed fluid therapy through the first postoperative morning and using each patient’s nighttime baseline MAP increased fluid balance, norepinephrine exposure, and MAP, but did not reduce 30-day morbidity measured by the Comprehensive Complication Index.
Impact: The trial rigorously tested an attractive precision-hemodynamic strategy and found no patient-outcome benefit despite clear physiologic treatment differences, directly challenging routine extension of individualized postoperative GDFT.
Clinical Implications: Routine extension of this individualized GDFT and nighttime-baseline MAP protocol after esophagectomy should not be assumed to improve outcomes; clinicians should balance protocol complexity, fluids, and vasopressors against demonstrated benefit.
Key Findings
- Intervention increased postoperative fluid balance by 516 mL.
- Norepinephrine use was higher with extended individualized therapy: 7,894 versus 4,611 μg median.
- Thirty-day Comprehensive Complication Index was unchanged: 39.0 versus 39.2.